TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157%
In this article:
TG Therapeutics stock popped Tuesday after the drugmaker unexpectedly reported a second-quarter profit, thanks to significantly lower R&D.
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
TG Therapeutics stock popped Tuesday after the drugmaker unexpectedly reported a second-quarter profit, thanks to significantly lower R&D.